Navigation Links
Vical to Present at Cowen and Company Health Care Conference
Date:3/12/2008

BOSTON, March 12 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) announced today that the company will present an overview of its product development programs on Monday, March 17, at the 28th Annual Cowen and Company Health Care Conference (Boston -- March 17-20).

About Vical

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements about the company's focus, collaborative partners, product candidates, and developmental status. Risks and uncertainties include whether any product candidates will be shown to be safe and efficacious in clinical trials, the timing of clinical trials, whether Vical or its collaborative partners will seek or gain approval to market any product candidates, the dependence of the company o
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vical to Present at BIO and BVGH Global Health Partnering Event
2. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
3. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
4. New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia
5. Vical Launches Redesigned Website
6. Vical Presentation at Military Pandemic Influenza Workshop
7. Amedica Receives FDA 510(k) Clearance for Valeo(TM) Cervical Plate
8. Vical to Present at Investor Conferences
9. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
10. Vical Announces News Release and Conference Call Schedule for Third Quarter 2007 Financial Results
11. Nventa updates progress of cervical dysplasia trial with new HspE7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Ontotext S4 , The Self Service Semantic ... Now the same enterprise hardened text mining, Linked Data ... is available to start-ups and mid-size businesses at a ... do not have resources to evaluate and prototype enterprise ... there is no need for on premise hardware provisioning ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 On Wednesday of ... gel to use Redox Signaling molecules, became available for purchase ... overwhelming. , "The way that RENU 28 works is, if ... slowing down of the rate of cellular renewal within your ... the increasing of that rate of cellular renewal. What RENU ...
(Date:8/20/2014)... school history lessons often have it that American Indians ... cough, chicken pox, influenza and tuberculosis brought to the ... estimates vary, about 20 million people lived in the ... of them were killed by European diseases., But new ... State University and Johannes Krause of the University of ...
(Date:8/20/2014)... 2014 High performance computing (HPC) ... most complete climate and Earth system model to ... issues. , Eight national laboratories, including Lawrence ... Center for Atmospheric Research, four academic institutions and ... participating national laboratories include Argonne, Brookhaven, Lawrence Berkeley, ...
Breaking Biology Technology:Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4RENU 28 Skin Care Now Available in Australia and New Zealand 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3
... June 6, 2011 Avantra® Biosciences, a leading ... Prototyping Service. Avantra,s new service allows researchers to ... designed biomarker assays developed on Avantra,s proven QPDx™ ... easy-to-use, quantitative multiplex protein assays using catalog or ...
... June 4, 2011 To aid the fight of ... Europe, BGI-Shenzhen and their collaborators at the University Medical ... result built upon the sequencing data previously released and ... one of the first genomes assembled using the latest ...
... FluoroPharma Medical (OTC.BB: FPMI), a biopharmaceutical company ... the change of its official stock ticker symbol from ... with the previously announced FluoroPharma Inc. merger with CEWM. ... is a biopharmaceutical company engaged in the discovery and ...
Cached Biology Technology:Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 2Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 3FluoroPharma Medical Announces Stock Ticker Symbol Change 2
(Date:8/22/2014)... , August 22, 2014 ... ) has announced the addition of ... 2014-2018"  report to their offering.  ... ,Biometrics is a technology that helps ... on their physical or behavioral features. ...
(Date:8/22/2014)... RIVERSIDE, Calif. Thomson Reuters , a leading ... five researchers at the University of California, Riverside in ... brightest minds of our times." , To generate the ... (2002-2012) to identify researchers whose published work has had ... included among some 3,200 individuals who published the greatest ...
(Date:8/22/2014)... Research presented at the 29th Annual International Papillomavirus ... Hera Therapeutics Inc. combats three types of human ... of all cervical cancer. , When tested in ... replication of HPV-16, HPV-18 and HPV-11 cells, according ... Ph.D., who presented the findings at the Seattle ...
Breaking Biology News(10 mins):Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 2Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 35 UC Riverside scientists among world's most influential scientific minds 2
... being launched to try to boost the income of the ... time provide consumers with more nutritious, better tasting food. , ... quality rice varieties that could fetch a higher price from ... , The main aim of the new International Network for ...
... the United States appears to be strongly associated with ... conducted by Paul Winchester, M.D., professor of clinical pediatrics ... his findings May 7 at the Pediatric Academic Societies' ... Society, the Society for Pediatric Research, the Ambulatory Pediatric ...
... Hopkins undergraduates have invented a device to improve cell ... inside a major blood vessel. , A team ... Hopkins doctors and engineers, devised a protective "pouch" that ... the liver. This pouch would keep microcapsules of therapeutic ...
Cached Biology News:New knowledge improves rice quality 2Premature births may be linked to seasonal levels of pesticides and nitrates in surface water 2Students invent protective pouch to enhance cell therapy 2Students invent protective pouch to enhance cell therapy 3Students invent protective pouch to enhance cell therapy 4
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
...
Biology Products: